WebDOI: 10.2217/fon-2024-0901 Abstract Patients with myelofibrosis (MF) who discontinue ruxolitinib due to progression/resistance have poor prognoses. JAK inhibitors control symptoms and reduce spleen volumes with limited impact on underlying disease pathophysiology. WebEarly intervention in myelofibrosis and impact on outcomes: A pooled analysis of the COMFORT-I and COMFORT-II studies Authors Srdan Verstovsek 1 , Jean-Jacques Kiladjian 2 , Alessandro M Vannucchi 3 , Ruben A Mesa 4 , Peg Squier 5 , J E Hamer-Maansson 5 , Claire Harrison 6 Affiliations
Long-term outcomes of polycythemia vera patients treated with
Webjean-yves yves jean-jacques bonello bertrand blay nguyen discovid phrci / seri-covid-iv meinzer ulrich edica chu de toulouse acket blandine a-nemis chu de limoges phrck valade sandrine ... kiladjian mithridate gcs unicancer mir gerico14_sts institut claudius regaud courbon neuroblu02 regis haplo-rescue entz-werle natacha plgg–mektric gist-ten_01 WebBaveno VII – Renewing consensus in portal hypertension. zekunliu 发表于 1 分钟前 显示全部楼层. 悬赏 10 积分. 我来应助. 期刊:Journal of Hepatology. artisan suribachi set
A PHASE 1/2 STUDY OF INCB000928 AS MONOTHERAPY OR IN COMBINATION…
Web12 apr 2024 · Jean-Jacques Kiladjian, Jean-Jacques Kiladjian Hôpital Saint-Louis & Université de Paris, Paris, France. Search for other works by this author on: This Site. PubMed. Google Scholar. Alessandro M. Vannucchi, Alessandro M. Vannucchi Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy. Web22 ago 2024 · Jean-Jacques Kiladjian is Professor of Clinical Pharmacology at Paris Diderot University, consultant Hematologist and … Web24 feb 2024 · Jean-Jacques Kiladjian. Medical University of Plovdiv, Plovdiv, Bulgaria. Pencho Georgiev. Teaching Unit of the Hematology Department, University Hospital in … artisan table orlando menu